Showing results (351-360 of 421) with videos related to

Sort By:
Pageof 43
The American Journal of Gastroenterology|August 30, 2019
Patients With Nonalcoholic Steatohepatitis Experience Severe Impairment of Health-Related Quality of LifeZobair M Younossi, Maria Stepanova, Eric J Lawitz, et al.
Nature Genetics|April 1, 1996
A locus for bipolar affective disorder on chromosome 4pD H Blackwood, L He, S W Morris, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 4, 2019
Long-term Benefits of Sustained Virologic Response for Patient-Reported Outcomes in Patients With Chronic Hepatitis C Virus InfectionZobair M Younossi, Maria Stepanova, Andrei Racila, et al.
Contemporary Clinical Trials|July 15, 2018
The Hepatitis C-Alcohol Reduction Treatment (Hep ART) intervention: Study protocol of a multi-center randomized controlled trialRae Jean Proeschold-Bell, Donna M Evon, Christina Makarushka, et al.
Nucleic Acids Research|July 26, 2002
SNP genotyping on pooled DNAs: comparison of genotyping technologies and a semi automated method for data storage and analysisStéphanie Le Hellard, Stéphane J Ballereau, Peter M Visscher, et al.
Hepatology (Baltimore, Md.)|September 25, 2014
Cardiac dysfunction associated with a nucleotide polymerase inhibitor for treatment of hepatitis CTariq Ahmad, Philip Yin, Jeffrey Saffitz, et al.
Hepatology (Baltimore, Md.)|February 15, 2012
Dysregulation of innate immunity in hepatitis C virus genotype 1 IL28B-unfavorable genotype patients: impaired viral kinetics and therapeutic responseSusanna Naggie, Anu Osinusi, Antonios Katsounas, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 9, 2008
Safety and antiviral activity of albinterferon alfa-2b in prior interferon nonresponders with chronic hepatitis CDavid R Nelson, Vinod Rustgi, Vijayan Balan, et al.
Journal of Clinical Gastroenterology|May 16, 2014
Sustained virologic response rates with telaprevir-based therapy in treatment-naive patients evaluated by race or ethnicitySteven L Flamm, Andrew J Muir, Michael W Fried, et al.
Pageof 43